Study S000338

A Randomized Controlled Trial Comparing the Safety and Efficacy of Liraglutide Versus Glargine Insulin for the Management of Patients With Type 2 Diabetes After Hospital Discharge

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT01919489
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 273
Start: 2014-03
Primary completion: 2020-08-30
Lead sponsor: Emory University
Conditions: Type 2 Diabetes
Interventions: DRUG:Liraglutide + OADs; DRUG:Glargine + OADs
Results posted: TRUE
Secondary identifiers: REGISTRY:(UTN) U1111-1139-2991

Registered primary outcomes

Glycemic Control at Hospital Discharge and 6 Months Follow up [Hospital discharge, 6 months (26 weeks)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.